The 8th Annual
Pre-Filled Syringes West Coast Conference will be back for 2024 in the West Coast to bring together device developers, biotech and big pharma. This year's conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.
As part of our leading injectable drug delivery conferences this is a must attend event; not only will the conference bring you key insights to enhance your drug device portfolio, but it will also give you the opportunity to network with key industry players. We hope to welcome you in June 2024!
What will you gain?
- Engage in discussions on evolving EU and US regulations as well as reviewing the latest FDA guidance on human factors and drawing insights from successful notified body opinions for streamlined regulatory compliance.
- Gain insight into advancements in large volume drug delivery devices with a case study from Halozyme and a panel discussion assessing key considerations, benefits and barriers of such devices for stakeholders including patients, HCPs and pharma companies.
- Delve into comprehensive strategies for maximizing combination product manufacturing and effectively managing your product’s lifecycle with key insights from GSK and Merck
- Acquire insights into human factors best practices from AbbVie and Regeneron, and discover ways to effectively apply testing and validation approaches for combination products.
- Explore collaborative opportunities to advance innovation in the injectables field and gain insight into the latest technology updates and challenges these pose such as leaching in electro-mechanical devices.
Who should attend
Directors, Heads of Departments and Managers for the following areas:
- Device Development
- Device Engineering
- Combination Product Development
- Drug Delivery Devices
- Primary Packaging Development
- Digital Health
- Large Volume Drug Delivery
- Novel Drug Product Formulation
- Regulatory Affairs
Featured Speakers
- Amin Sedighiamiri, Director, Device Development, AstraZeneca
- Bidisha Nandi, Human Factors Engineer, Regeneron Pharmaceuticals
- Jian Liu, Sr Principal Scientist, Amgen
- Kimberly VanCuren, Senior Principal Human Factors Engineer, AbbVie
- Kinsuk Shah, Sr. AD Combination Product Steward, Boehringer Ingelheim
- Li-Chun Tsou, Director, Global Device Engineering and Technologies, GSK
- Marie Printz, Executive Director, Bioanalytical & Nonclinical Sciences, Halozyme Therapeutics
- Mitch Zhao, Engineering Fellow, JnJ Innovative Medicine
- Monica Swinney, Sr. Director, New Product Planning & Drug Delivery Innovation, Gilead Sciences
- Natalie Abts, Head of Human Factors Engineering, Genentech
- Paul Upham, Head, Smart Devices, Roche-Genentech
- Ram Halthore, Director of Engineering, Merck
- Respresentative to be confirmed, Food and Drug Administration
- Speaker to be confirmed, UserWise
- Speaker to be confirmed, Instron Corp.
- Speaker to be confirmed, CCL Industries
- Speaker to be confirmed, Credence MedSystems
- Speaker to be confirmed, Haselmeier GmbH
- Speaker to be confirmed, Mitsubishi Gas Chemical Company, Inc
- Speaker to be confirmed, Zeon Specialty Materials
- Speaker to be confirmed, Datwyler
- Stephanie Smith, Principal Human Factors Engineer, Genentech
- Tina Rees, Associate Director, Human Factors, Regeneron Pharmaceuticals
- Tyler A Novak, Associate Director, Device Development, Gilead Sciences
- Wenjing Wang, Associate Principal Scientist in Regulatory Affairs, Merck & Co
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
San Diego Marriott La Jolla
4240 La Jolla Village Drive,
La Jolla, San Diego, Callifornia, USA
